Publikationen, an denen er mitarbeitet RAQUEL MUÑOZ MARTINEZ (39)

2013

  1. In vitro and in vivo effects of an anti-mouse endoglin (CD105)-immunotoxin on the early stages of mouse B16MEL4A5 melanoma tumours

    Cancer Immunology, Immunotherapy, Vol. 62, Núm. 3, pp. 541-551

2012

  1. Transient injury-dependent up-regulation of CD105 and its specific targeting with an anti-vascular anti-mouse endoglin-nigrin b immunotoxin

    Medicinal Chemistry, Vol. 8, Núm. 6, pp. 996-1002

2007

  1. Targeting a marker of the tumour neovasculature using a novel anti-human CD105-immunotoxin containing the non-toxic type 2 ribosome-inactivating protein nigrin b

    Cancer Letters, Vol. 256, Núm. 1, pp. 73-80

2005

  1. Cytotoxicity of an ebulin l-anti-human CD105 immunotoxin on mouse fibroblasts (L929) and rat myoblasts (L6E9) cells expressing human CD105.

    Medicinal chemistry, Vol. 1, Núm. 1, pp. 65-70

  2. Specific dose-dependent damage of Lieberkühn crypts promoted by large doses of type 2 ribosome-inactivating protein nigrin b intravenous injection to mice

    Toxicology and Applied Pharmacology, Vol. 207, Núm. 2, pp. 138-146

2003

  1. Evidence for distinct cellular internalization pathways of ricin and nigrin b.

    Cellular and molecular biology (Noisy-le-Grand, France), Vol. 49 Online Pub

  2. Non-toxic type 2 ribosome-inactivating proteins (RIPs) from Sambucus: occurrence, cellular and molecular activities and potential uses.

    Cellular and molecular biology (Noisy-le-Grand, France), Vol. 49, Núm. 4, pp. 537-545

2002

  1. Targeting cancer cells with transferrin conjugates containing the non-toxic type 2 ribosome-inactivating proteins nigrin b or ebulin l

    Cancer Letters, Vol. 184, Núm. 1, pp. 29-35

2001

  1. Sensitivity of cancer cell lines to the novel non-toxic type 2 ribosome-inactivating protein nigrin b

    Cancer Letters, Vol. 167, Núm. 2, pp. 163-169

1996

  1. Differential sensitivity of HELA cells to the type 2 ribosome-inactivating proteins ebulin l, nigrin b and nigrin f as compared with ricin.

    Cellular and molecular biology (Noisy-le-Grand, France), Vol. 42, Núm. 4, pp. 473-476

  2. Recent advances in the uses and applications of ribosome-inactivating proteins from plants.

    Cellular and molecular biology (Noisy-le-Grand, France), Vol. 42, Núm. 4, pp. 461-471

1995

  1. A new procedure for the preparation of highly active melonin from the dry seeds of Cucumis melo L.

    Cellular and molecular biology (Noisy-le-Grand, France), Vol. 41, Núm. 2, pp. 279-287

1994

  1. Cusativin, a new cytidine-specific ribonuclease accumulated in seeds of Cucumis sativus L.

    Planta, Vol. 194, Núm. 3, pp. 328-338

  2. Elderberry (Sambucus nigra L.) seed proteins inhibit protein synthesis and display strong immunoreactivity with rabbit polyclonal antibodies raised against the type 2 ribosome-inactivating protein nigrin b

    Journal of Experimental Botany, Vol. 45, Núm. 4, pp. 513-516

  3. Isolation and characterization of two new N-glycosidase type-1 ribosome-inactivating proteins, unrelated in amino-acid sequence, from Petrocoptis species

    Planta, Vol. 194, Núm. 4, pp. 487-491

1993

  1. A Cucumis sativus cell‐free translation system: preparation, optimization and sensitivity to some antibiotics and ribosome inactivating proteins

    Physiologia Plantarum, Vol. 88, Núm. 4, pp. 549-556

  2. Development of a cell-free translation system from Cucumis melo: preparation, optimization and evaluation of sensitivity to some translational inhibitors

    Plant Science, Vol. 90, Núm. 2, pp. 127-134

  3. Ebulin 1, a nontoxic novel type 2 ribosome-inactivating protein from Sambucus ebulus L. leaves

    Journal of Biological Chemistry, Vol. 268, Núm. 24, pp. 18195-18199

  4. Isolation and partial characterization of nigrin b, a non-toxic novel type 2 ribosome-inactivating protein from the bark of Sambucus nigra L.

    Plant Molecular Biology, Vol. 22, Núm. 6, pp. 1181-1186

  5. Messenger-dependent action of the pokeweed antiviral protein and fusidic acid on in vitro Vicia sativa L. translation.

    Cellular and molecular biology (Noisy-le-Grand, France), Vol. 39, Núm. 3, pp. 333-337